Drug General Information |
Drug ID |
DXT9WU
|
Drug Name |
4-[2-(3-Hydroxy-phenylamino)-pyrimidin-4-yl]-3,5-dimethyl-1H-pyrrole-2-carbonitrile
|
Synonyms |
CHEMBL360530
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C17H15N5O
|
Canonical SMILES |
Cc1[nH]c(C#N)c(C)c1c2ccnc(Nc3cccc(O)c3)n2
|
InChI |
InChI=1S/C17H15N5O/c1-10-15(9-18)20-11(2)16(10)14-6-7-19-17(22-14)21-12-4-3-5-13(23)8-12/h3-8,20,23H,1-2H3,(H,19,21,22)
|
InChIKey |
JYNCERXNUWYBKO-UHFFFAOYSA-N
|
Target and Pathway |
Target(s) |
Cell division protein kinase 2 |
Target Info |
|
[1]
|
Cell division protein kinase 4 |
Target Info |
|
[1]
|
KEGG Pathway
|
FoxO signaling pathway
|
Cell cycle
|
Oocyte meiosis
|
p53 signaling pathway
|
PI3K-Akt signaling pathway
|
Progesterone-mediated oocyte maturation
|
Hepatitis B
|
Measles
|
Herpes simplex infection
|
Epstein-Barr virus infection
|
Pathways in cancer
|
Viral carcinogenesis
|
Prostate cancer
|
Small cell lung cancerhsa04110:Cell cycle
|
Tight junction
|
T cell receptor signaling pathway
|
HTLV-I infection
|
Pancreatic cancer
|
Glioma
|
Melanoma
|
Bladder cancer
|
Chronic myeloid leukemia
|
Small cell lung cancer
|
Non-small cell lung cancer
|
NetPath Pathway
|
TCR Signaling PathwayNetPath_11:TCR Signaling Pathway
|
EGFR1 Signaling Pathway
|
RANKL Signaling Pathway
|
PANTHER Pathway
|
p53 pathway
|
p53 pathway feedback loops 2
|
Pathway Interaction Database
|
Regulation of nuclear SMAD2/3 signaling
|
Signaling events mediated by PRL
|
p73 transcription factor network
|
E2F transcription factor network
|
ATR signaling pathway
|
mTOR signaling pathway
|
IL2-mediated signaling events
|
FoxO family signaling
|
FOXM1 transcription factor network
|
BARD1 signaling events
|
p53 pathway
|
Regulation of retinoblastoma proteinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
Validated targets of C-MYC transcriptional activation
|
ATF-2 transcription factor network
|
Regulation of retinoblastoma protein
|
Reactome
|
G0 and Early G1
|
Activation of ATR in response to replication stress
|
Regulation of APC/C activators between G1/S and early anaphase
|
SCF(Skp2)-mediated degradation of p27/p21
|
Senescence-Associated Secretory Phenotype (SASP)
|
DNA Damage/Telomere Stress Induced Senescence
|
Processing of DNA double-strand break ends
|
G2 Phase
|
Orc1 removal from chromatin
|
Cyclin E associated events during G1/S transition
|
Cyclin A/B1 associated events during G2/M transition
|
p53-Dependent G1 DNA Damage Response
|
Cyclin A:Cdk2-associated events at S phase entry
|
Meiotic recombination
|
Factors involved in megakaryocyte development and platelet productionR-HSA-2559580:Oxidative Stress Induced Senescence
|
Oncogene Induced Senescence
|
RMTs methylate histone arginines
|
Transcriptional regulation of white adipocyte differentiation
|
Ubiquitin-dependent degradation of Cyclin D1
|
Cyclin D associated events in G1
|
WikiPathways
|
DNA Damage Response
|
ID signaling pathway
|
DNA Replication
|
G1 to S cell cycle control
|
M/G1 Transition
|
S Phase
|
Meiotic Recombination
|
Aryl Hydrocarbon Receptor
|
ATM Signaling Pathway
|
Retinoblastoma (RB) in Cancer
|
Spinal Cord Injury
|
Integrated Pancreatic Cancer Pathway
|
Oncostatin M Signaling Pathway
|
Prostate Cancer
|
Signaling Pathways in Glioblastoma
|
TSH signaling pathway
|
Integrated Breast Cancer Pathway
|
Integrated Cancer pathway
|
Synthesis of DNA
|
Regulation of DNA replication
|
Mitotic G2-G2/M phases
|
Mitotic G1-G1/S phases
|
Factors involved in megakaryocyte development and platelet production
|
Cell Cycle
|
APC/C-mediated degradation of cell cycle proteins
|
Cell Cycle Checkpoints
|
miRNA Regulation of DNA Damage ResponseWP707:DNA Damage Response
|
Ovarian Infertility Genes
|
PPAR Alpha Pathway
|
Bladder Cancer
|
Transcriptional Regulation of White Adipocyte Differentiation
|
miRNA Regulation of DNA Damage Response
|
References |
REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |